Sofinnova, Polaris lead CHF 54m series-A for Noema
Sofinnova Partners and Polaris Partners have co-led a CHF 54m series-A round for Noema Pharma, a Swiss clinical-stage company targeting orphan neurological disorders.
More on Early-stage
Gorillas raises circa USD 1bn in Delivery Hero-led Series C
New funding comes just seven months after a Series B, with the company doubling in value
French mega-rounds shoot up in 2021
France has already seen as many rounds of EUR 100m and above than in 2019 and 2020 combined, Unquote Data shows
L Catterton et al. in EUR 100m round for SellerX
SellerX has already raised amost EUR 250m in debt and equity in its 12 months since inception
Mega-rounds fuel record H1 for venture and growth
Largest rounds inked in the first six months of 2021 read like a veritable Who's Who of European fintech heavyweights
Latest News
Verdane acquires marketing software developer Papirfly
GP is investing in the Norway-based marketing technology group via its EUR 540m Edda II fund
IDI to buy minority stake in Omnes
Further details are expected to be announced in the coming six weeks, according to a statement
Gimv acquires specialist building materials company GSDI
Paris-based manufacturer of construction surface films records annual turnover of more than EUR 30m
Softbank Vision Fund leads EUR 200m Series D for Paack
Paack, now valued at EUR 1bn, has pledged to be the first delivery service to be 100% emission-free